Novo Nordisk (NVON) Stock Forecast & Price Target
NVON Analyst Ratings
Hold
0Buy6Hold1Sell
Based on 7 analysts giving stock ratings to Novo Nordisk in the past 3 months
NVON Stock 12 Month Forecast
Average Price Target
MXN 793.78▲(6.37% Upside)Based on 7 Wall Street analysts offering 12 month price targets for Novo Nordisk in the last 3 months. The average price target is MXN 793.78 with a high forecast of MXN 877.14 and a low forecast of MXN 746.51. The average price target represents a 6.37% change from the last price of MXN 746.28.
Past 12 Months12 Month ForecastDec2025Sep2026
HighMXN 877.14
AverageMXN 793.78
LowMXN 746.51
Highest Price TargetHighestMXN 877.14Average Price TargetMXN 793.78Lowest Price TargetLowestMXN 746.51
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Kerry Holford | Berenberg Bank | MXN 877.14 | hold | 17.54%Upside | Reiterated | 10/13/26 | ||
| Evan Seigerman | BMO Capital | MXN 877.14→MXN 746.51 | hold | 0.03%Upside | Reiterated | 10/12/26 | ||
 Unknown AnalystNot Ranked | Jefferies | MXN 787.56 | hold | 5.53%Upside | Reiterated | 09/22/26 | ||
| Michael Nedelcovych | TD Cowen | MXN 783.83 | hold | 5.03%Upside | Reiterated | 09/22/26 | ||
| Thibault Boutherin | Morgan Stanley | MXN 746.51 | sell | 0.03%Upside | Downgraded | 09/11/26 | ||
| Jasper Hellweg | Argus Research | ― | hold | ― | Reiterated | 08/07/26 | ||
| James Quigley | Goldman Sachs | MXN 895.81→MXN 821.16 | hold | 10.03%Upside | Reiterated | 08/06/26 | ||
| Martin Brenoe | Nordea Markets | ― | hold | ― | Downgraded | 02/24/26 | ||
| Emmanuel Papadakis | Deutsche Bank | ― | hold | ― | Downgraded | 02/23/26 | ||
| Rajesh Kumar | HSBC | MXN 877.14→MXN 1,007.78 | hold | 35.04%Upside | Reiterated | 12/10/25 | ||
| Richard Vosser | J.P. Morgan | ― | buy | ― | Reiterated | 11/24/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Kerry Holford | 10/13/26 | MXN 877.14 | hold | 17.54%Upside | Reiterated | Berenberg Bank | ||
| Evan Seigerman | 10/12/26 | MXN 877.14→MXN 746.51 | hold | 0.03%Upside | Reiterated | BMO Capital | ||
| Unknown AnalystNot Ranked | 09/22/26 | MXN 787.56 | hold | 5.53%Upside | Reiterated | Jefferies | ||
| Michael Nedelcovych | 09/22/26 | MXN 783.83 | hold | 5.03%Upside | Reiterated | TD Cowen | ||
| Thibault Boutherin | 09/11/26 | MXN 746.51 | sell | 0.03%Upside | Downgraded | Morgan Stanley | ||
| Jasper Hellweg | 08/07/26 | ― | hold | ― | Reiterated | Argus Research | ||
| James Quigley | 08/06/26 | MXN 895.81→MXN 821.16 | hold | 10.03%Upside | Reiterated | Goldman Sachs | ||
| Martin Brenoe | 02/24/26 | ― | hold | ― | Downgraded | Nordea Markets | ||
| Emmanuel Papadakis | 02/23/26 | ― | hold | ― | Downgraded | Deutsche Bank | ||
| Rajesh Kumar | 12/10/25 | MXN 877.14→MXN 1,007.78 | hold | 35.04%Upside | Reiterated | HSBC | ||
| Richard Vosser | 11/24/25 | ― | buy | ― | Reiterated | J.P. Morgan |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Novo Nordisk
3 Months
Success Rate4/7 ratings generated profit
57%
Average Return
+0.86%
Copying Richard Vosser's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.86% per trade.
1 Year
Success Rate4/7 ratings generated profit
57%
Average Return
+4.24%
Copying Richard Vosser's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +4.24% per trade.
2 Years
Success Rate4/7 ratings generated profit
57%
Average Return
+22.97%
Copying Richard Vosser's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +22.97% per trade.
NVON Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 8 | 13 | 15 | 16 |
| Sell | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 6 | 8 | 13 | 16 | 17 |
In the current month, NVON has received 0 Buy Ratings, 16 Hold Ratings, and 1 Sell Ratings. NVON average Analyst price target in the past 3 months is 793.78.
NVON Financial Forecast
HighMXN 14.93
ConsensusMXN 13.73
LowMXN 12.74
NVON Earnings Forecast
Next quarter’s earnings estimate for NVON is MXN 13.73 with a range of MXN 12.74 to MXN 14.93. The previous quarter’s EPS was MXN 17.94. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighMXN 221B
ConsensusMXN 208B
LowMXN 201B
NVON Sales Forecast
Next quarter’s sales forecast for NVON is MXN 208.19B with a range of MXN 200.63B to MXN 221.41B. The previous quarter’s sales results were MXN 229.40B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
NVON Stock Forecast FAQ
What is MX:NVON’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk’s 12-month average price target is Mex$793.78.
What is MX:NVON’s upside potential, based on the analysts’ average price target?
Novo Nordisk has 6.37% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novo Nordisk a Buy, Sell or Hold?
Novo Nordisk has a consensus rating of Hold, which is based on 0 buy ratings, 6 hold ratings and 1 sell ratings.
What is Novo Nordisk’s share price target?
The average share price target for Novo Nordisk is Mex$793.78. This is based on 7 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$877.14, and the lowest forecast is Mex$746.51. The average share price target represents a 6.37% increase from the current price of Mex$746.28.
What do analysts say about Novo Nordisk?
Novo Nordisk’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of Novo Nordisk?
To buy shares of MX:NVON, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.